Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective

R Wang, T Yuan, J Wang, Y Chen, J Zhao, M Li… - Pharmacological …, 2022 - Elsevier
Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary dysfunctional disease,
characterized by progressive vascular remodeling. Inflammation is an increasingly …
被引用次数：37 相关文章

Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective.

RR Wang, TY Yuan, JM Wang, YC Chen… - Pharmacological …, 2022 - europepmc.org
Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary dysfunctional disease,
characterized by progressive vascular remodeling. Inflammation is an increasingly …

Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective

RR Wang, TY Yuan, JM Wang… - Pharmacological …, 2022 - pubmed.ncbi.nlm.nih.gov
Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary dysfunctional disease,
characterized by progressive vascular remodeling. Inflammation is an increasingly …